Evidence map›Paper›PMID 38310421›Full record

ArticleArchives of Iranian medicine2023

Breast Cancer Sentinel Lymph Node Detection Rate: First Large Scale Multi-Centric Data for Technetium Phytate.

Ramesh Omranipour, Mehrshad Abassi, Newsha Nazarian, Bardia Gholami, Samareh Heydari, Bita Eslami, Alireza Abdollahi, Sadaf Alipour

Erratum issuedOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Archives of Iranian medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ramesh OmranipourBreast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-4785-281X
Mehrshad AbassiDepartment of Nuclear Medicine, Vali-Asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Newsha NazarianFaculty of Medicine, Tehran Medical Branch, Islamic Azad University.
Bardia GholamiBreast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Samareh HeydariBreast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Bita EslamiBreast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Alireza AbdollahiDepartment of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Sadaf AlipourBreast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-7451-4077
Tehran University of Medical Sciences · IRImam Khomeini Hospital · IRShahid Beheshti University of Medical Sciences · IRIslamic Azad University Medical Branch of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSentinel lymph node biopsy (SLNB) with injection of radiopharmaceuticals is now the standard of care for staging the axilla in patients with breast cancer. Sulfur or antimony colloids labeled with

methodsThis is a retrospective cross-sectional multicenter study. Participants were breast cancer patients without previous history of axillary surgery, who underwent sentinel node biopsy using Tc phytate on the morning of surgery or the day before. The detection rate was calculated as the number of patients with histologically positive sentinel nodes to all patients with histologically positive lymph nodes; we compared those injected on the day of surgery and those injected on the day before.

resultsOverall, 2663 women aged 50.2±11.6 years were included. The detection rate was 91.8% (806 out of 878). The false negative rate was 8.2% overall, and statistically similar for injections on the day or the day before surgery (2.9 vs 2.1;

conclusionTc phytate has a good detection rate for breast radio-guided SLNB with similar result for injections on the surgery day or the day before it.

Indexed as

Breast NeoplasmsOrganotechnetium CompoundsSentinel Lymph NodeCross-Sectional StudiesFemaleHumansLymph NodesPhytic AcidRadionuclide ImagingRetrospective StudiesSentinel Lymph Node BiopsyOrganotechnetium CompoundsPhytic Acidtechnetium phytateAxillary stagingBreast cancerRadioisotope scanSentinel node

Identifiers

PMID38310421
PMCPMC10864942
OpenAlexW4391716682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.